Message from ASCPT President on Recent US Supreme Court Decision

Author: [AUTHOR] Published on 6/27/2022 7:36:00 AM

ASCPT Statement on Dobbs v. Jackson

Dear Colleague:

The recent US Supreme Court decision in Dobbs v. Jackson Women’s Health Organization reverses nearly 50 years of protection for women in reproductive health and bodily autonomy. The implications of this ruling will gravely impact the personal lives and health decisions of millions of Americans, and result in restrictions, regulations, and bans that will serve patients poorly. As President of ASCPT, I wish to voice our strong opposition to this decision, which will have a detrimental impact on the health, safety, and autonomy of millions.  

ASCPT’s mission is focused on the benefits that clinical pharmacology and translational science bring to the safe and effective treatment of all patients and society. Sadly, there is nothing in the Supreme Court decision to benefit patients who find themselves in need of abortion care. As an organization that is focused on promoting scientific advancements, ASCPT opposes a decision that will disproportionately impact those who already face barriers to effective healthcare, including people of color, those living in rural areas, and those without the financial resources to gain access to health care. As scientists focused on improving health outcomes for patients, we cannot overlook the negative effects this decision will have on patient safety, health equity, and the patient perspective, all of which are critically important to the members of our Society. 

As leaders in drug discovery, development, regulation, and safe use, ASCPT will continue to support our members and patients when faced with any attempt to prohibit access to evidence-based health care.
Mark J. Dresser, PhD

Sort by:
Photo Gallery
Recent News
Contact Us